Previous Page  51 / 164 Next Page
Information
Show Menu
Previous Page 51 / 164 Next Page
Page Background

311

40. Brandman S, Ko JP. Pulmonary nodule detection,

characterization, and management with multidetector

computed tomography. J Thorac Imaging. 2011;26(2):90-105.

41. Siegelman SS, Zerhouni EA, Leo FP, Khouri NF, Stitik FP. CT

of the solitary pulmonary nodule. AJR Am J Roentgenol.

1980;135(1):1-13.

42. Zwirewich CV, Vedal S, Miller RR, Muller NL. Solitary pulmonary

nodule: high-resolution CT and radiologic-pathologic

correlation. Radiology. 1991;179(2):469-476.

43. Swensen SJ, Viggiano RW, Midthun DE, et al. Lung nodule

enhancement

at

CT:

multicenter

study.

Radiology.

2000;214(1):73-80.

44. Christensen JA, Nathan MA, Mullan BP, et al. Characterization

of the solitary pulmonary nodule: 18F-FDG PET versus nodule-

enhancement CT. AJR Am J Roentgenol 2006;187(5):1361-

1367.

45. Henschke CI, McCauley DI, Yankelevitz DF, et al. Early lung

cancer action project: a summary of the findings on baseline

screening. Oncologist. 2001;6(2):147-152.

46. Hollings N, Shaw P. Diagnostic imaging of lung cancer. Eur

Respir J. 2002;19(4):722-742.

47. Zerhouni EA, Stitik FP, Siegelman SS, et al. CT of the pulmonary

nodule: a cooperative study. Radiology. 1986;160(2):319-

327.

48. Godoy MC, Naidich DP. Subsolid pulmonary nodules and

the spectrum of peripheral adenocarcinomas of the lung:

recommended interim guidelines for assessment and

management. Radiology. 2009;253(3):606-622.

49. MacMahon H, Austin JHM, Gamsu G, Herold CJ, Jett JR, Naidich

DP, Patz EF, Swensen SJ. Guidelines for Management of Small

Pulmonary Nodules Detected on CT Scans: A Statement from

the Fleischner Society. Radiology 2005, 237(2): 395–400.

50. Naidich DP, Bankier AA, MacMahon H, Schaefer-Prokop CM,

Pistolesi M, Goo JM, Macchiarini P, Crapo JD, Herold CJ, Austin

JH, Travis WD. Recommendations for the Management of

Subsolid Pulmonary Nodules Detected at CT: A Statement from

the Fleischner Society. Radiology 2013, 266(1): 304-317.

51. Henschke CI, Wisnivesky JP, Yankelevitz DF, Miettinen OS. Small

stage I cancers of the lung: genuineness and curability. Lung

Cancer. 2003;39(3):327-330.

52. Noguchi M, Morikawa A, Kawasaki M, Matsuno Y,Yamada T,

Hirohashi S, Kondo H, Shimosato Y. Small Adenocarcinoma

of the Lung. Histologic Characteristics and Prognosis. CANCER

1995, 75 (12): 2844-2852.

53. Asamura H. Minimally invasive approach to early, peripheral

adenocarcinoma with ground-glass opacity appearance. Ann

Thorac Surg. 2008 Feb;85(2):S701-4.

54. Godoy MC, Naidich DP. Overview and strategic management

of subsolid pulmonary nodules. J Thorac Imaging.

2012;27(4):240-248.

55. Lee HJ, Goo JM, Lee CH, et al. Nodular ground-glass opacities on

thin-section CT: size change during follow-up and pathological

results. Korean J Radiol 2007;8(1):22-31.

56. Nakata M, Saeki H, Takata I, et al. Focal ground-glass opacity

detected by low-dose helical CT. Chest 2002;121(5):1464-

1467

57. Park CM, Goo JM, Lee HJ, et al. Nodular ground-glass opacity

at thin-section CT: histologic correlation and evaluation of

change at follow-up. Radiographics 2007;27(2):391-408.

58. Humphrey LL, Teutsch S, Johnson M. Lung Cancer Screening

with Sputum Cytologic Examination, ChestRadiography, and

Computed Tomography: An Update forthe U.S. Preventive

Services Task Force. Ann Intern Med. 2004;140:740-753.

59. Canals M, Barros A, Barros P, Triviño R, Berrios R, Bannura F.

Hallazgos de imagen en Tomografía Computada de voluntarios

fumadores de larga data. Rev Chil Radiol; 2009, 15(3):

105-109.

60. Gil R, Florenzano M, Ibarra C, Baehr F, Del Solar A, Parada MT,

Rodríguez JC. Cáncer Pulmonar Prevención y Pesquiza Precoz.

Rev Med Clin Condes 2011; 22(4): 500-507.

61. Clavero J.M., Huete A. y Aparicio R. Detección Precoz de Cáncer

Pulmonar en población de alto riesgo. Rev Chil Enf Respir 2005;

21: 270

62. H, de Koning H, Vernhout R, Nackaerts K, Prokop M, Weenink

C, Lammers JW, Groen H, Oudkerk M, van Klaveren R. Nodule

managemente protocol of the NELSON randomised lung cancer

screening trial. Lung Cancer. 2006;54(2):177-84.

63. Solomon CG, Gould MK. Lung-Cancer Screening with Low-Dose

Computed Tomography. NEJM ,2014; 371(19): 1813–1820.

64. Horeweg N, van der Aalst CM, Thunnissen E, Nackaerts K,

Weenink C, Groen HJM, Lammers JJ, Aerts JG, Scholten ET,van

Rosmalen J, Mali W, Oudkerk M, de Koning HJ. Characteristics

of Lung Cancers Detected by Computer Tomography Screening

in the Randomized NELSON Trial. Am J Respir Crit Care Med Vol

187, Iss. 8, pp 848–854, Apr 15, 2013

65. Shlomi D, D Shlomi, Ben-Avi R, Balmor GR, Onn A, Peled N.

Screening for lung cancer: time for large-scale screening by

chest computed tomography. Eur Resp J 2014; 44(1):217–238.

66. Manser R, Wright G, Hart D, Byrnes G, Campbell D, Wainer Z, Tort

S. Surgery for local and locally advanced non-small cell lung

cancer. Cochrane Database of Systematic Reviews 2005, Issue

1. Art. No.: CD004699. DOI: 10.1002/14651858. CD004699.

pub2.

67. Lardinois D, De Leyn P, Van Schil P, Rami Porta R, Waller D. ESTS

guidelines for intraoperative lymph node staging in non-small

cell lung cancer. European Journal of Cardio-Thoracic Surgery

2006, 30(5): 787–792.

68. Allen MS, Darling GE, Pechet TTV, et al. Morbidity and mortality

of major pulmonary resections in patients with early-stage

lung cancer: Initial results of the randomized, prospective

ACOSOG Z0030 Trial. Ann Thorac Surg. 2006;81:1013-20.

69. Kodama K, Doi O, Higashiyama M, Yokouchi H. Intentional

Limited resection for Selected Patients with T1N0M0

Non-Small-Cel Lung Cancer: a Single Institution Study. J

Thorac Cardiovasc Surg 1997;114: 347-53

70. Asamura H, Grunenwald D. Extent of surgical resection for stage

I and II lung cancer.. Pass HI, Ball D, Scagliotti GV (eds) The IASLC

Multidisciplinary Approach to Thoracic Oncology. Aurora, CO:

[Nódulos Pulmonares - Dr. José Miguel Clavero R.]